Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome
are some of the most common disorders. A thrombus either arises spontaneously or is …

Hospitalized patients with acute medical conditions are at significant risk of venous
thromboembolism (VTE): approximately 10–30% of general medical patients may develop …

Heparin-induced thrombocytopenia (HIT) is an uncommon but potentially devastating
complication of anticoagulation with unfractionated heparin (UFH) or low-molecular-weight …

Background Prophylaxis against deep-vein thrombosis in hospitalized patients remains
underused. We hypothesized that the use of a computer-alert program to encourage …

The clinical importance of asymptomatic proximal and distal deep vein thrombosis (DVT)
remains uncertain and controversial. The aim of this retrospective, post-hoc analysis was to …

Although traditional anticoagulant regimens are highly effective and safe in most patients
with venous thromboembolism (VTE), the aggressive natural history of VTE and the high risk …

Background We were concerned that a fixed rather than a weight-based dosing regimen of
dalteparin sodium to prevent venous thromboembolism (VTE) might result in decreased …

Objectives To determine the incidence of clinical pulmonary embolism (PE) in a population
with severe congestive heart failure (CHF) admitted to a coronary care unit (CCU), and to …

Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients.
Over the past 5 years, three large‐scale placebo‐controlled trials enrolling a total of 5500 …

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality in
hospitalized patients with acute medical illness. The high prevalence of VTE in this patient …